Eli Lilly Taps Amazon to Deliver Its Weight Management Blockbuster. Is It Time to Buy the Pharma Stock?
It's hard to overstate just how successful the expansions of new diabetes treatments into the weight management arena have been for the companies that sell them. In one striking example, the market capitalization of Novo Nordisk (NYSE: NVO), formerly a relatively obscure drugmaker that until recently mostly sold diabetes treatments, recently exceeded the market cap of .
Eli Lilly's (NYSE: LLY) newest weight management drug, Zepbound, is already on pace to outperform Novo Nordisk's Wegovy. And a new distribution partnership with Amazon (NASDAQ: AMZN) may accelerate sales of Zepbound even faster.
Could this Amazon Pharmacy partnership make Eli Lilly a smarter stock to buy now?
Source Fool.com
Tesla Inc Stock
€156.46
-2.240%
Currently there is a rather positive sentiment for Tesla Inc with 56 Buy predictions and 27 Sell predictions.
As a result the target price of 248 € shows a very positive potential of 58.51% compared to the current price of 156.46 € for Tesla Inc.
